Login
Navigate Fool.com
Will RAD beat
the market?

Rite Aid Corp

NYSE: RAD

Community Rating: 2 Stars: Unattractive

3.14 0.05 (1.62%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.14
Previous Close $3.09
Daily Range $3.11 - $3.18
52-Week Range $0.95 - $3.21
Market Cap $2.9B
P/E Ratio 25.75
Dividend (Yield) $0.00 (0.0%)
Volume 20,940,712
Average Daily Volume 21,389,859
Current FY EPS $0.17

How do you think RAD
will perform against the market?

Top RAD Bull/Bear Pitches

 

remaxholt (0)
Submitted May 6, 2011

History, stabalized debt., high Pharmacy sales %.

0 Replies Reply Report this Post
 

stockfreak1 (19.13)
Submitted July 14, 2010

The capital markets have given up on this company in issuing any more debt. The only thing left for them to do is issue a billion more shares or dive deeper into the well which will eventually screw s … More

1 Replies Reply Report this Post

News & Commentary

5 Stocks Under $10

It's all about the Hamiltons.

Rite Aid Announces Offering of Senior Notes as Part of a Refinancing of Certain of Its Outstanding I

This Week: Three Stocks to Move the Market

Is Walgreen Innovating Itself into Oblivion?

3 Predictions for Next Week

This Fool sees a limb to go out on.

The Fool Looks Ahead

It will be an interesting week if you know where to look.

WEEK AHEAD: FedEx, Oracle, Darden to Report Earnings

The Business Drivers Supporting CVS Caremark’s Outperformance

Rite Aid and The Skin Cancer Foundation Join to Promote Simple Summer Steps for Healthy, Glowing Ski

5 Companies That Haven't Earned Their Keep

Investors should understand that these five companies have only done one thing well lately: Lose money.

See More RAD News...

Sector

Services

Industry

Retail

Rite Aid Corp (RAD) Description

The Company is a Delaware corporation and through its wholly-owned subsidiaries, operates retail drugstores in the United States of America. Website: http://www.riteaid.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks